1
|
Bajaj SS, Jain B, Potter AL, Dee EC, Yang CFJ. Racial and ethnic disparities in end-of-life care for patients with oesophageal cancer: death trends over time. LANCET REGIONAL HEALTH. AMERICAS 2023; 17:100401. [PMID: 36776566 PMCID: PMC9904053 DOI: 10.1016/j.lana.2022.100401] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/02/2022] [Revised: 10/17/2022] [Accepted: 11/03/2022] [Indexed: 05/20/2023]
Abstract
Background Given significant morbidity and mortality associated with oesophageal cancer, supportive, high-quality end-of-life care is critical. Most patients with advanced cancer prefer to die at home, but incongruence between preferred and actual place of death is common. Here, we examined trends and disparities in location of death among patients with oesophageal cancer. Methods Using the Centers for Disease Control and Prevention Wide-Range Online Data for Epidemiologic Research database, we utilized multinomial logistic regression to assess associations between sociodemographic characteristics and location of death for patients with oesophageal cancer (n = 237,063). Additionally, we utilized linear regression models to evaluate the significance of changes in location of death trends over time and disparities in the relative change in location of death trends across sociodemographic groups. Findings From 2003 to 2019, there was a decrease of deaths in hospitals, nursing homes, and outpatient medical facilities/emergency departments and an increase of deaths at home and in hospice. Relative to White decedents, Black and Asian decedents were less likely to die at home (relative risk ratio (RRR): 0.58 [95% confidence interval (CI): 0.56-0.60], RRR: 0.57 [95% CI: 0.53-0.61]) and in hospice (RRR: 0.67 [95% CI: 0.64-0.71], RRR: 0.49 [95% CI: 0.43-0.55]) when compared to the hospital. Similar disparities were noted for American Indian and Alaska Native (AIAN) decedents. These disparities persisted even upon stratifying by the number of listed causes of death, a proxy for severity of illness. Time trend analysis indicated that increases in deaths in hospice over time occurred at a slower rate for AIAN and Asian decedents relative to White decedents. Interpretation 2 in 5 patients with oesophageal cancer die at home, with an increasing proportion dying at home and in hospice-in line with general patient preferences. However, location of death disparities have largely persisted over time among racial and ethnic minority groups. Our findings suggest the importance of improving access to advance care planning and delivering tailored, person-centred interventions. Funding None.
Collapse
Affiliation(s)
- Simar S. Bajaj
- Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
| | - Bhav Jain
- Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
| | - Alexandra L. Potter
- Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
| | - Edward Christopher Dee
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Chi-Fu Jeffrey Yang
- Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
- Corresponding author. Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.
| |
Collapse
|
2
|
Wang W, Liu Y, Ye P, Liu J, Yin P, Qi J, You J, Lin L, Wang F, Wang L, Huo Y, Zhou M. Trends and associated factors in place of death among individuals with cardiovascular disease in China, 2008-2020: A population-based study. THE LANCET REGIONAL HEALTH - WESTERN PACIFIC 2022; 21:100383. [PMID: 35540560 PMCID: PMC9079349 DOI: 10.1016/j.lanwpc.2022.100383] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Background Cardiovascular disease (CVD) is the leading cause of death (COD) in China. Understanding the characteristics of place of death (POD) among CVD deaths would be of great importance to evaluate the healthcare service utilization at the end stage of life. Limited studies have reported the POD distribution among CVD deaths, and little was known about the associated factors of hospital CVD deaths. Methods By using data from National Mortality Surveillance System (NMSS) in China, this study presented the characteristics of POD distribution during 2008 and 2020. Afterwards, multilevel logistic regression was used to explore associated factors of hospital CVD deaths and quantify the magnitude to which the spatial variations of hospital CVD deaths could be explained by those associated factors. Findings During 2008-2020, there was 7101871 CVD deaths collected by NMSS in China, with 77·13% home deaths and 18·49% hospital deaths. Shanghai (59·40%) had the highest percentage of hospital CVD deaths. Age, sex, ethnicity, marital status, education, occupation, underlying COD were significant influential factors of hospital CVD deaths. Spatial variations were shown at provincial level, with 33·88% of them being explained by factors at individual level. Interpretation Home was the leading POD among CVD deaths in China, those CVD decedents characterized as the female, the youngest, Han population, the married, the retiree, lived in urban areas, with higher socioeconomic status and died of chronic CVDs had a higher probability of hospital deaths. Providing accessible and available healthcare services were priorities to improve quality of end-of-life care, significant variations among provinces and sub-population also reminded us of the requirements for equal healthcare resources allocation and multiple options for minorities of POD preference at the end stage of life. Funding National Key Research & Development Program of China (grant number 2018YFC1315301)
Collapse
Affiliation(s)
- Wei Wang
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Yunning Liu
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Pengpeng Ye
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Jiangmei Liu
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Peng Yin
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Jinlei Qi
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Jinling You
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Lin Lin
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Feixue Wang
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Lijun Wang
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Yong Huo
- Department of Cardiology, Peking University First Hospital, Beijing, China
- Prof. Yong Huo, Department of Cardiology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, China, Tel: 010-83575725, Fax: 010-66551211
| | - Maigeng Zhou
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
- Correspondence to Prof. Maigeng Zhou, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 27 Nanwei Road, Xicheng District, Beijing, 100050, China, Tel: 86-10-63041471, Fax: 86-10-63042350.
| |
Collapse
|
3
|
Barbaro M, Blinderman CD, Iwamoto FM, Kreisl TN, Welch MR, Odia Y, Donovan LE, Joanta-Gomez AE, Evans KA, Lassman AB. Causes of Death and End-of-Life Care in Patients With Intracranial High-Grade Gliomas: A Retrospective Observational Study. Neurology 2021; 98:e260-e266. [PMID: 34795049 PMCID: PMC8792811 DOI: 10.1212/wnl.0000000000013057] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2021] [Accepted: 11/05/2021] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND AND OBJECTIVES To understand patterns of care and circumstances surrounding end of life in patients with intracranial gliomas. METHODS We retrospectively analyzed end-of-life circumstances in patients with intracranial high-grade gliomas at Columbia University Irving Medical Center who died from January 2014 through February 2019, including cause of death, location of death, and implementation of comfort measures and resuscitative efforts. RESULTS There were 152 patients (95 men, 57 women; median age at death 61.5 years, range 24-87 years) who died from 1/2014-2/2019 with adequate data surrounding end-of-life circumstances. Clinical tumor progression (n=117, 77.0%) was the most common cause of death with all patients transitioned to comfort measures. Other causes included, but were not limited to, infection (19, 12.5%); intratumoral hemorrhage (5, 3.3%); seizures (8, 5.3%); cerebral edema (4, 2.6%); pulmonary embolism (4, 2.6%); autonomic failure (2, 1.3%); and hemorrhagic shock (2, 1.3%). Multiple mortal events were identified in 10 (8.5%). Seventy-three patients (48.0%) died at home with hospice. Other locations were inpatient hospice (40, 26.3%); acute care hospital (34, 22.4%) including 27 (17.8%) with and 7 (4.6%) without comfort measures; skilled nursing facility (4, 3.3%) including 3 (2.0%) with and 1 (0.7%) without comfort measures; or religious facility (1, 0.7%) with comfort measures. Acute cardiac and/or pulmonary resuscitation was performed in 20 patients (13.2%). DISCUSSION Clinical tumor progression was the most common (77.0%) cause of death followed by infection (12.5%). Hospice or comfort measures were ultimately implemented in 94.7% of patients, though resuscitation was performed in 13.2%. Improved understanding of circumstances surrounding death, frequency of use of hospice services, and frequency of resuscitative efforts in patients with gliomas may allow physicians to more accurately discuss end-of-life expectations with patients and caregivers, facilitating informed care planning.
Collapse
Affiliation(s)
- Marissa Barbaro
- Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola, NYU Long Island School of Medicine, NYU Langone Health, Mineola, NY, USA
| | - Craig D Blinderman
- Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Division of Hematology/Oncology, Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA
| | - Fabio M Iwamoto
- Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA
| | - Teri N Kreisl
- Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Novartis AG, East Hanover, NJ, USA
| | - Mary R Welch
- Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA
| | - Yazmin Odia
- Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA
| | - Laura E Donovan
- Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,James J. Peters Department of Veterans Affairs Medical Center
| | - Adela E Joanta-Gomez
- Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA
| | - Katharine A Evans
- Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA.,Montefiore Health System, New York, NY, USA
| | - Andrew B Lassman
- Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA .,Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, NY, USA
| |
Collapse
|
4
|
Ailshire J, Osuna M, Wilkens J, Lee J. Family Caregiving and Place of Death: Insights From Cross-national Analysis of the Harmonized End-of-Life Data. J Gerontol B Psychol Sci Soc Sci 2021; 76:S76-S85. [PMID: 33378449 DOI: 10.1093/geronb/gbaa225] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2019] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVES Family is largely overlooked in research on factors associated with place of death among older adults. We determine if family caregiving at the end of life is associated with place of death in the United States and Europe. METHOD We use the Harmonized End of Life data sets developed by the Gateway to Global Aging Data for the Survey of Health, Ageing and Retirement in Europe (SHARE) and the Health and Retirement Study (HRS). We conducted multinomial logistic regression on 7,113 decedents from 18 European countries and 3,031 decedents from the United States to determine if family caregiving, defined based on assistance with activities of daily living, was associated with death at home versus at a hospital or nursing home. RESULTS Family caregiving was associated with reduced odds of dying in a hospital and nursing home, relative to dying at home in both the United States and Europe. Care from a spouse/partner or child/grandchild was both more common and more strongly associated with place of death than care from other relatives. Associations between family caregiving and place of death were generally consistent across European welfare regimes. DISCUSSION This cross-national examination of family caregiving indicates that family-based support is universally important in determining where older adults die. In both the United States and in Europe, most care provided during a long-term illness or disability is provided by family caregivers, and it is clear families exert tremendous influence on place of death.
Collapse
Affiliation(s)
- Jennifer Ailshire
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, US
| | - Margarita Osuna
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, US
| | - Jenny Wilkens
- Center for Economic and Social Research (CESR), University of Southern California, Los Angeles, US
| | - Jinkook Lee
- Center for Economic and Social Research (CESR), University of Southern California, Los Angeles, US
| |
Collapse
|
5
|
Cheng HWB, Lam KO. Supportive and palliative care in hemato-oncology: how best to achieve seamless integration and subspecialty development? Ann Hematol 2021; 100:601-606. [PMID: 33388859 DOI: 10.1007/s00277-020-04386-8] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Accepted: 12/21/2020] [Indexed: 12/16/2022]
Abstract
While recent medical advances have led to cure, remission, or long-term disease control for patients with hematologic malignancy, many still portend poor prognoses, and frequently are associated with significant symptom and quality of life burden for patients and families. Patients with hematological cancer are referred to palliative care (PC) services less often than those with solid tumors, despite higher inpatient mortality and shorter interval between first consultation and death. The complexity of individual prognostication, ongoing therapeutic goals of cure, the technical nature and complications of treatment, the intensity of medical care even when approaching end of life, and the speed of change to a terminal event all pose difficulties and hinder referral. A modified palliative care model is an unmet need in hemato-oncology, where PC is introduced early from the diagnosis of hematological malignancy, provided alongside care of curative or life-prolonging intent, and subsequently leads to death and bereavement care or cure and survivorship care depending on disease course. From current evidence, the historical prioritization of cancer care at the center of palliative medicine did not guarantee that those diagnosed with a hematological malignancy were assured of referral, timely or otherwise. Hopefully, this article can be a catalyst for debate that will foster a new direction in integration of clinical service and research, and subspecialty development at the interface of hemato-oncology and palliative care.
Collapse
Affiliation(s)
- Hon Wai Benjamin Cheng
- Medical Palliative Care Team, Department of Medicine & Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong.
| | - Ka On Lam
- Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong
| |
Collapse
|
6
|
Halling CMB, Wolf RT, Sjøgren P, Von Der Maase H, Timm H, Johansen C, Kjellberg J. Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial. BMC Palliat Care 2020; 19:142. [PMID: 32933489 PMCID: PMC7493170 DOI: 10.1186/s12904-020-00645-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2019] [Accepted: 09/02/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND While hospitals remain the most common place of death in many western countries, specialised palliative care (SPC) at home is an alternative to improve the quality of life for patients with incurable cancer. We evaluated the cost-effectiveness of a systematic fast-track transition process from oncological treatment to SPC enriched with a psychological intervention at home for patients with incurable cancer and their caregivers. METHODS A full economic evaluation with a time horizon of six months was performed from a societal perspective within a randomised controlled trial, the DOMUS trial ( Clinicaltrials.gov : NCT01885637). The primary outcome of the health economic analysis was a incremental cost-effectiveness ratio (ICER), which is obtained by comparing costs required per gain in Quality-Adjusted Life Years (QALY). The costs included primary and secondary healthcare costs, cost of intervention and informal care from caregivers. Public transfers were analysed in seperate analysis. QALYs were measured using EORTC QLQ-C30 for patients and SF-36 for caregivers. Bootstrap simulations were performed to obtain the ICER estimate. RESULTS In total, 321 patients (162 in intervention group, 159 in control group) and 235 caregivers (126 in intervention group, 109 in control group) completed the study. The intervention resulted in significantly higher QALYs for patients when compared to usual care (p-value = 0.026), while being more expensive as well. In the 6 months observation period, the average incremental cost of intervention compared to usual care was €2015 per patient (p value < 0.000). The mean incremental gain was 0.01678 QALY (p-value = 0.026). Thereby, the ICER was €118,292/QALY when adjusting for baseline costs and quality of life. For the caregivers, we found no significant differences in QALYs between the intervention and control group (p-value = 0.630). At a willingness to pay of €80,000 per QALY, the probability that the intervention is cost-effective lies at 15% in the base case scenario. CONCLUSION This model of fast-track SPC enriched with a psychological intervention yields better QALYs than usual care with a large increase in costs. TRIAL REGISTRATION The trial was prospectively registered 25.6.2013. Clinicaltrials.gov Identifier: NCT01885637 .
Collapse
Affiliation(s)
| | - Rasmus Trap Wolf
- VIVE - The Danish Center for Social Science Research, Herluf Trolles Gade 11, 1052, København K, Denmark
| | - Per Sjøgren
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.,Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
| | - Hans Von Der Maase
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.,Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
| | - Helle Timm
- REHPA - The Danish Knowledge Centre for Rehabilitation and Palliative Care, Copenhagen, Denmark
| | - Christoffer Johansen
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.,The Danish Cancer Society, Copenhagen, Denmark
| | - Jakob Kjellberg
- VIVE - The Danish Center for Social Science Research, Herluf Trolles Gade 11, 1052, København K, Denmark
| |
Collapse
|
7
|
Sun Z, Guerriere DN, de Oliveira C, Coyte PC. Temporal trends in place of death for end-of-life patients: Evidence from Toronto, Canada. HEALTH & SOCIAL CARE IN THE COMMUNITY 2020; 28:1807-1816. [PMID: 32364288 DOI: 10.1111/hsc.13007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/07/2019] [Revised: 04/01/2020] [Accepted: 04/03/2020] [Indexed: 06/11/2023]
Abstract
Understanding the temporal trends in the place of death among patients in receipt of home-based palliative care can help direct health policies and planning of health resources. This paper aims to assess the temporal trends in place of death and its determinants over the past decade for patients receiving home-based palliative care. This paper also examines the impact of early referral to home-based palliative care services on patient's place of death. Survey data collected in a home-based end-of-life care program in Toronto, Canada from 2005 to 2015 were analysed using a multivariate logistic model. The results suggest that the place of death for patients in receipt of home-based palliative care has changed over time, with more patients dying at home over 2006-2015 when compared to 2005. Also, early referral to home-based palliative care services may not increase a patient's likelihood of home death. Understanding the temporal shifts of place of death and the associated factors is essential for effective improvements in home-based palliative care programs and the development of end-of-life care policies.
Collapse
Affiliation(s)
- Zhuolu Sun
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - Denise N Guerriere
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
- Canadian Center for Health Economics, Toronto, ON, Canada
| | - Claire de Oliveira
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
- Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada
- Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada
| | - Peter C Coyte
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
- Canadian Center for Health Economics, Toronto, ON, Canada
| |
Collapse
|
8
|
Xu W, Wu C, Fletcher J. Assessment of changes in place of death of older adults who died from dementia in the United States, 2000-2014: a time-series cross-sectional analysis. BMC Public Health 2020; 20:765. [PMID: 32522179 PMCID: PMC7288493 DOI: 10.1186/s12889-020-08894-0] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2019] [Accepted: 05/11/2020] [Indexed: 11/23/2022] Open
Abstract
BACKGROUND As the mortality attributable to dementia-related diseases in the United States escalates, providing quality and equitable end-of-life care for dementia patients across care settings has become a major public health challenge. Previous research suggests that place of death may be an indicator of quality of end-of-life care. This study aims to examine the geographical variations and temporal trends in place of death of dementia decedents in the US and the relationships between place of death of dementia decedents and broad structural determinants. METHODS Using nationwide death certificates between 2000 and 2014, we described the changes in place of death of dementia decedents across states and over time. Chi-square test for trend in proportions was used to test significant linear trend in the proportion of dementia decedents at difference places. State fixed effects models were estimated to assess the relationships between the proportion of dementia decedents at difference places and state-level factors, particularly availability of care facility resources and public health insurance expenditures. RESULTS Dementia decedents were more likely to die at home and other places and less likely to die at institutional settings over the study period. There was wide inter-state and temporal variability in the proportions of deaths at different places. Among state-level factors, availability of nursing home beds was positively associated with rates of nursing home/long term care deaths and negatively associated with rates of home deaths. Medicaid expenditure on institutional long term supports and services was positively associated with rates of nursing home/long term care deaths and negatively associated with rates of home deaths. Medicaid expenditure on home and community based services, however, had a positive association with rates of home deaths. CONCLUSIONS There was a persistent shift in the place of death of dementia decedents from institutions to homes and communities. Increased investments in home and community based health services may help dementia patients to die at their homes. As home becomes an increasingly common place of death of dementia patients, it is critical to monitor the quality of end-of-life care at this setting.
Collapse
Affiliation(s)
- Wei Xu
- Center for Demography of Health and Aging, University of Wisconsin – Madison, Madison, WI USA
| | - Changshan Wu
- Department of Geography, University of Wisconsin – Milwaukee, Milwaukee, WI USA
| | - Jason Fletcher
- Center for Demography of Health and Aging, University of Wisconsin – Madison, Madison, WI USA
- La Follette School of Public Affairs, Departments of Sociology, Agricultural and Applied Economics, and Population Health Sciences, University of Wisconsin – Madison, Madison, WI USA
| |
Collapse
|
9
|
Roeland EJ, Lindley LC, Gilbertson-White S, Saeidzadeh S, Currie ER, Friedman S, Bakitas M, Mack JW. End-of-life care among adolescent and young adult patients with cancer living in poverty. Cancer 2019; 126:886-893. [PMID: 31724747 DOI: 10.1002/cncr.32609] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2019] [Revised: 09/05/2019] [Accepted: 10/07/2019] [Indexed: 12/16/2022]
Abstract
BACKGROUND To the authors' knowledge, end-of-life (EOL) care outcomes among adolescents and young adults (AYAs) with cancer who are living in poverty remain poorly understood. The primary aim of the current study was to examine the effect of poverty on EOL care for AYA patients with cancer. METHODS The authors conducted a multisite, retrospective study of AYA patients with cancer aged 15 to 39 years who died between January 2013 and December 2016 at 3 academic sites. Medical record-based EOL care outcomes included hospice referral, palliative care (PC) consultation, cancer treatment within the last month of life, and location of death. Two measures of poverty were applied: 1) zip code with a median income ≤200% of the federal poverty level; and 2) public insurance or lack of insurance. Logistic regression analyses were conducted. RESULTS A total of 252 AYA cancer decedents were identified. Approximately 41% lived in a high-poverty zip code and 48% had public insurance or lacked insurance; approximately 70% had at least 1 poverty indicator. Nearly 40% had a hospice referral, 60% had a PC consultation (76% on an inpatient basis), 38% received EOL cancer treatment, and 39% died in the hospital. In bivariable analyses, AYA patients living in low-income zip codes were found to be less likely to enroll in hospice (P ≤ .01), have an early PC referral (P ≤ .01), or receive EOL cancer treatment (P = .03), although only EOL cancer treatment met statistical significance in multivariable models. No differences with regard to location of death (P = .99) were observed. CONCLUSIONS AYA patients with cancer experience low rates of hospice referral and high rates of in-hospital death regardless of socioeconomic status. Future studies should evaluate early inpatient PC referrals as a possible method for improving EOL care.
Collapse
Affiliation(s)
- Eric J Roeland
- Department of Oncology and Palliative Medicine, Massachusetts General Hospital, Boston, Massachusetts
| | - Lisa C Lindley
- College of Nursing, University of Tennessee at Knoxville, Knoxville, Tennessee
| | | | | | - Erin R Currie
- School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama
| | - Sarah Friedman
- University of California at San Diego, San Diego, California
| | - Marie Bakitas
- School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama
| | - Jennifer W Mack
- Division of Population Sciences, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.,Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts
| |
Collapse
|
10
|
Trends in Place of Death Among Patients With Gynecologic Cancer in the United States. Obstet Gynecol 2019; 131:1111-1120. [PMID: 29742673 DOI: 10.1097/aog.0000000000002614] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
OBJECTIVE To describe the change over time in place of death (hospital, home, hospice) among all women in the United States who died of gynecologic malignancies and compare them with other leading causes of female cancer deaths. METHODS This is a retrospective cross-sectional study using national death certificate data from the Mortality Multiple Cause-of-Death Public Use Record Data. All women who died from gynecologic, breast, lung, and colorectal cancers were identified according to International Classification of Diseases, 10 Revision, cause of death from 2003 to 2015. Regression analyses with ordinary least-squares linear probability modeling were used to test for differences in location of death over time, and differences in trends by cancer type, while controlling for age, race, ethnicity, marital status, and education status. RESULTS From 2003 to 2015, 2,133,056 women died from gynecologic, lung, breast, and colorectal malignancies in the United States. A total of 359,340 died from gynecologic malignancies, including ovarian cancer (n=188,366 [52.4%]), uterine cancer (n=106,454 [29.6%]), cervical cancer (n=52,320 [14.6%]), and vulvar cancer (n=12,200 [3.4%]). Overall, 49.2% (n=176,657) of gynecologic cancer deaths occurred at home or in hospice. The relative increase from 2003 to 2015 in the rate of deaths at home or in hospice was 47.2% for gynecologic cancer deaths (40.5% in 2003 to 59.5% in 2015). In adjusted analyses, the trend in the percentage of deaths at home or in hospice increased at a rate of 1.6 percentage points per year for gynecologic cancer deaths (95% CI 1.5-1.6) vs 1.5 (95% CI 1.4-1.5, P<.001), 1.4 (95% CI 1.4-1.5, P<.001), and 1.5 (95% CI 1.4-1.5, P=.09) percentage points per year for lung, breast, and colorectal cancer deaths, respectively. CONCLUSION Between 2003 and 2015, there was a 47.2% increase (40.5-59.5%) in the rates of gynecologic cancer deaths occurring at home or in hospice. This trend may represent an increase in advance care planning and value-based treatment decisions.
Collapse
|
11
|
Affiliation(s)
- Eduardo Bruera
- The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
| |
Collapse
|
12
|
Grande GE, Mckerral A, Addington-Hall JM, Todd CJ. Place of Death and Use of Health Services in the Last Year of Life. J Palliat Care 2019. [DOI: 10.1177/082585970301900408] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Aim To investigate whether health service input in the last year of life differs between cancer patients who die at home versus those dying in inpatient care. Methods Post hoc exploratory case-control study of 127 home deaths and 200 inpatient deaths. Retrospective electronic record linkage of patients’ community and inpatient care during the last year of life. Results Patients who died at home began their home nursing care closer to death than those who died as inpatients. Their first contact with inpatient hospice care began further from death. Before their final month, home death patients also had more specialist and district nursing than patients who died in inpatient care. Conclusions Patients who began their home nursing early were less likely to die at home than those who began such care late. This suggests that it may be difficult to sustain end-of-life care at home for an extended period. Further research incorporating assessment of informal care input and disease trajectory is required to investigate this issue.
Collapse
Affiliation(s)
- Gunn E. Grande
- School of Nursing, Midwifery and Health Visiting, University of Manchester, Manchester
| | | | | | - Chris J. Todd
- School of Nursing, Midwifery and Health Visiting, University of Manchester, Manchester, U.K
| |
Collapse
|
13
|
Disparities in place of death for patients with hematological malignancies, 1999 to 2015. Blood Adv 2019; 3:333-338. [PMID: 30709864 PMCID: PMC6373747 DOI: 10.1182/bloodadvances.2018023051] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2018] [Accepted: 12/04/2018] [Indexed: 11/20/2022] Open
Abstract
Patients with hematologic malignancies (HMs) often receive aggressive end-of-life care and less frequently use hospice. Comprehensive longitudinal reporting on place of death, a key quality indicator, is lacking. Deidentified death certificate data were obtained via the National Center for Health Statistics for all HM deaths from 1999 to 2015. Multivariate regression analysis (MVA) was used to test for disparities in place of death associated with sociodemographic variables. During the study period, there were 951 435 HM deaths. Hospital deaths decreased from 54.6% in 1999 to 38.2% in 2015, whereas home (25.9% to 32.7%) and hospice facility deaths (0% to 12.1%) increased (all P < .001). On MVA of all cancers, HM patients had the lowest odds of home or hospice facility death (odds ratio [OR], 0.55; 95% confidence interval, 0.54-0.55). Older age (40-64 years: OR, 1.34; ≥65 years: OR, 1.89), being married (OR, 1.62), and having myeloma (OR, 1.34) were associated with home or hospice facility death, whereas being black or African American (OR, 0.68), Asian (OR, 0.58), or Hispanic (OR, 0.84) or having chronic leukemia (OR, 0.83) had decreased odds of dying at home or hospice (all P < .001). In conclusion, despite hospital deaths decreasing over time, patients with HMs remained more likely to die in the hospital than at home.
Collapse
|
14
|
Piggott KL, Patel A, Wong A, Martin L, Patel A, Patel M, Liu Y, Dhesy-Thind S, You JJ. Breaking silence: a survey of barriers to goals of care discussions from the perspective of oncology practitioners. BMC Cancer 2019; 19:130. [PMID: 30736754 PMCID: PMC6368724 DOI: 10.1186/s12885-019-5333-x] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2018] [Accepted: 01/30/2019] [Indexed: 11/26/2022] Open
Abstract
Background Cancer is the leading cause of death in the developed world, and yet healthcare practitioners infrequently discuss goals of care (GoC) with hospitalized cancer patients. We sought to identify barriers to GoC discussions from the perspectives of staff oncologists, oncology residents, and oncology nurses. Methods This was a single center survey of staff oncologists, oncology residents, and inpatient oncology nurses. Barriers to GoC discussions were assessed on a 7-point Likert scale (1 = extremely unimportant; 7 = extremely important). Results Between July 2013 and May 2014, of 185 eligible oncology clinicians, 30 staff oncologists, 10 oncology residents, and 28 oncology nurses returned surveys (response rate of 37%). The most important barriers to GoC discussions were patient and family factors. They included family members’ difficulty accepting poor prognoses (mean score 5.9, 95% CI [5.7, 6.2]), lack of family agreement in the goals of care (mean score 5.8, 95% CI [5.5, 6.1]), difficulty understanding the limitations of life-sustaining treatments (mean score 5.8, 95% CI [5.6, 6.1]), lack of patients’ capacity to make goals of care decisions (mean score 5.7, 95% CI [5.5, 6.0]), and language barriers (mean score 5.7, 95% CI [5.4, 5.9]). Participants viewed system factors and healthcare provider factors as less important barriers. Conclusions Oncology practitioners perceive patient and family factors as the most limiting barriers to GoC discussions. Our findings underscore the need for oncology clinicians to be equipped with strong communication skills to help patients and families navigate GoC discussions. Electronic supplementary material The online version of this article (10.1186/s12885-019-5333-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Katrina Lynn Piggott
- Department of Geriatric Medicine, 30 Bond Street, Room 4-002, Shuter Wing, Toronto, ON, M5B 1W8, Canada.
| | - Ameen Patel
- Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON, L8N 3Z5, Canada
| | - Arthur Wong
- Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON, L8N 3Z5, Canada
| | - Leslie Martin
- Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON, L8N 3Z5, Canada
| | - Alexandra Patel
- Department of Occupational Science and Occupational Therapy, The University of Toronto, 500 University Avenue, Toronto, ON, M5G 1V7, Canada
| | - Matthew Patel
- Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland
| | - Yudong Liu
- Schulich School of Dentistry, University of Western Ontario, 1151 Richmond St, London, ON, N6A 5C1, Canada
| | - Sukhbinder Dhesy-Thind
- Department of Oncology, McMaster University, 699 Concession St, Hamilton, ON, L8V 5C2, Canada
| | - John J You
- Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON, L8N 3Z5, Canada.,Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main St West, Hamilton, ON, L8S 4K1, Canada
| |
Collapse
|
15
|
Gill A, Laporte A, Coyte PC. Predictors of Home Death in Palliative Care Patients: A Critical Literature Review. J Palliat Care 2018. [DOI: 10.1177/082585971302900208] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Ashlinder Gill
- A Gill (corresponding author): Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, and Palliative Care Consult Team, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5
| | - Audrey Laporte
- Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Peter C. Coyte
- Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada, and Canadian Institutes of Health Research Strategic Training Program in Health Care, Technology and Place, Toronto, Ontario, Canada
| |
Collapse
|
16
|
Masucci L, Guerriere DN, Cheng R, Coyte PC. Determinants of place of Death for recipients of Home-Based Palliative Care. J Palliat Care 2018. [DOI: 10.1177/082585971002600404] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Introduction: Health system restructuring combined with the preferences of many terminally ill care recipients and their caregivers has led to an increase in home-based palliative care, yet many care recipients die within institutional settings such as hospitals. This study sought to determine the place of death and its predictors among palliative care patients with cancer. Methods: Study participants were re cruited from the Temmy Latner Centre for Palliative Care, a regional palliative care program based in Toronto, Canada. A total of 137 patients and their family caregivers participated in the study; application of various exclusion criteria restricted analysis to a sub-sample of 110. Bivariate (chi-square) and multivariate (logistic regression) analyses were conducted. Results: 66 percent of participants died at home. Chisquare analysis indicated that women were more likely to die at home than men; multivariate analysis indicated that women and those living with others were significantly more likely to die at home than men or those who lived alone. Conclusion: Place of death is influenced by the socio-demographic characteristics of patients, the characteristics of their caregivers, and health service factors. Palliative care programs need to tailor services to men and those living alone in order to reduce institutional deaths.
Collapse
Affiliation(s)
- Lisa Masucci
- L Masucci, DN Guerriere: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Denise N. Guerriere
- L Masucci, DN Guerriere: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Richard Cheng
- R Cheng: Life Sciences Program, University of Toronto, Toronto, Ontario, Canada
| | - Peter C. Coyte
- PC Coyte (corresponding author): Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, 155 College Street 4th Floor, Toronto, Ontario, Canada M5T 3M6
| |
Collapse
|
17
|
Karanth S, Rajan SS, Sharma G, Yamal JM, Morgan RO. Racial-Ethnic Disparities in End-of-Life Care Quality among Lung Cancer Patients: A SEER-Medicare-Based Study. J Thorac Oncol 2018; 13:1083-1093. [PMID: 29753578 DOI: 10.1016/j.jtho.2018.04.014] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2017] [Revised: 04/10/2018] [Accepted: 04/17/2018] [Indexed: 02/03/2023]
Abstract
INTRODUCTION Cancer end-of-life care and associated racial-ethnic disparities have been in focus during the last few years due to concerns regarding subjective care variations and poor quality of care. Given the high mortality rate and disease burden of lung cancer, end-of-life care quality is particularly crucial for this disease. This study uses previously validated measures and examines racial-ethnic disparities in lung cancer end-of-life care quality. METHODS This study involves retrospective analysis of patients ≥66 years, who were diagnosed with stage I-IV lung cancer, and who died on or before December 31, 2013, using the Surveillance Epidemiology and End Result-Medicare data from 1991-2013. Poor quality of care was measured using three themes: (1) potentially preventable medical encounters, (2) delayed hospice referral, and (3) aggressive chemotherapy provision during end-of-life. The patients were analyzed as two separate cohorts of NSCLC and SCLC patients. Logistic regression analyses were performed to estimate racial-ethnic disparities in the adjusted odds of receiving poor quality end-of-life care. RESULTS The study found considerable racial-ethnic disparities in end-of-life care quality. The racial-ethnic minorities had higher odds of experiencing potentially preventable medical encounters in the last month of life as compared with non-Hispanic whites. Odds of delayed hospice referral and aggressive chemotherapy provision during end-of-life were lower in non-Hispanic blacks as compared with non-Hispanic whites. CONCLUSIONS The study findings highlight the continued lack of access and care disparity among the minorities, which could precipitate potentially preventable utilizations, and limit access to hospice care during end-of-life. The study suggests the need to develop educational, patient navigational and other interventions that could potentially reduce aggressive utilizations and improve appropriate hospice care provision during end-of-life.
Collapse
Affiliation(s)
- Siddharth Karanth
- Department of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas
| | - Suja S Rajan
- Department of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas.
| | - Gulshan Sharma
- Division of Pulmonary Critical Care & Sleep Medicine, The University of Texas Medical Branch, Galveston, Texas
| | - Jose-Miguel Yamal
- Department of Biostatistics, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas
| | - Robert O Morgan
- Department of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas
| |
Collapse
|
18
|
Hudson KE, Wolf SP, Samsa GP, Kamal AH, Abernethy AP, LeBlanc TW. The Surprise Question and Identification of Palliative Care Needs among Hospitalized Patients with Advanced Hematologic or Solid Malignancies. J Palliat Med 2018; 21:789-795. [PMID: 29420142 DOI: 10.1089/jpm.2017.0509] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
BACKGROUND Little is known about quality of life (QOL), depression, and end-of-life (EOL) outcomes among hospitalized patients with advanced cancer. OBJECTIVE To assess whether the surprise question identifies inpatients with advanced cancer likely to have unmet palliative care needs. DESIGN Prospective cohort study and long-term follow-up. SETTING/SUBJECTS From 2008 to 2010, we enrolled 150 inpatients at Duke University with stage III/IV solid tumors or lymphoma/acute leukemia and whose physician would not be surprised if they died in less than one year. MEASUREMENTS We assessed QOL (FACT-G), mood (brief CES-D), and EOL outcomes. RESULTS Mean FACT-G score was quite low (66.9; SD 11). Forty-five patients (30%) had a brief CES-D score of ≥4 indicating a high likelihood of depression. In multivariate analyses, better QOL was associated with less depression (OR 0.91, p < 0.0001), controlling for tumor type, education, and spiritual well-being. Physicians correctly estimated death within one year in 101 (69%) cases, yet only 37 patients (25%) used hospice, and 4 (2.7%) received a palliative care consult; 89 (60.5%) had a do-not-resuscitate order, and 63 (43%) died in the hospital. CONCLUSIONS The surprise question identifies inpatients with advanced solid or hematologic cancers having poor QOL and frequent depressive symptoms. Although physicians expected death within a year, EOL quality outcomes were poor. Hospitalized patients with advanced cancer may benefit from palliative care interventions to improve mood, QOL, and EOL care, and the surprise question is a practical method to identify those with unmet needs.
Collapse
Affiliation(s)
| | - Steven Paul Wolf
- 2 Biostatistics Core, Duke University School of Medicine , Durham, North Carolina
| | - Gregory P Samsa
- 2 Biostatistics Core, Duke University School of Medicine , Durham, North Carolina
| | - Arif H Kamal
- 3 Duke Cancer Institute , Durham, North Carolina
| | - Amy Pickar Abernethy
- 4 Duke Clinical Research Institute , Durham, North Carolina
- 5 Flatiron Health , New York, New York
| | - Thomas William LeBlanc
- 3 Duke Cancer Institute , Durham, North Carolina
- 6 Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine , Durham, North Carolina
| |
Collapse
|
19
|
Saugo M, Pellizzari M, Marcon L, Benetollo P, Toffanin R, Gallina P, Cecchetto G, Miccinesi G, Rigon S, Cancian M, Sichetti D. Impact of Home Care on Place of Death, Access to Emergency Departments and Opioid Therapy in 350 Terminal Cancer Patients. TUMORI JOURNAL 2018; 94:87-95. [DOI: 10.1177/030089160809400117] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Daniela Sichetti
- Laboratorio di Farmacoepidemiologia, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy
| |
Collapse
|
20
|
Adelson K, Lee DKK, Velji S, Ma J, Lipka SK, Rimar J, Longley P, Vega T, Perez-Irizarry J, Pinker E, Lilenbaum R. Development of Imminent Mortality Predictor for Advanced Cancer (IMPAC), a Tool to Predict Short-Term Mortality in Hospitalized Patients With Advanced Cancer. J Oncol Pract 2017; 14:e168-e175. [PMID: 29206553 DOI: 10.1200/jop.2017.023200] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE End-of-life care for patients with advanced cancer is aggressive and costly. Oncologists inconsistently estimate life expectancy and address goals of care. Currently available prognostication tools are based on subjective clinical assessment. An objective prognostic tool could help oncologists and patients decide on a realistic plan for end-of-life care. We developed a predictive model (Imminent Mortality Predictor in Advanced Cancer [IMPAC]) for short-term mortality in hospitalized patients with advanced cancer. METHODS Electronic health record data from 669 patients with advanced cancer who were discharged from Yale Cancer Center/Smilow Cancer Hospital were extracted. Statistical learning techniques were used to develop a tool to estimate survival probabilities. Patients were randomly split into training (70%) and validation (30%) sets 20 times. We tested the predictive properties of IMPAC for mortality at 30, 60, 90, and 180 days past the day of admission. RESULTS For mortality within 90 days at a 40% sensitivity level, IMPAC has close to 60% positive predictive value. Patients estimated to have a greater than 50% chance of death within 90 days had a median survival time of 47 days. Patients estimated to have a less than 50% chance of death had a median survival of 290 days. Area under the receiver operating characteristic curve for IMPAC averaged greater than .70 for all time horizons tested. Estimated potential cost savings per patient was $15,413 (95% CI, $9,162 to $21,665) in 2014 constant dollars. CONCLUSION IMPAC, a novel prognostic tool, can generate life expectancy probabilities in real time and support oncologists in counseling patients about end-of-life care. Potentially avoidable costs are significant.
Collapse
Affiliation(s)
- Kerin Adelson
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Donald K K Lee
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Salimah Velji
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Junchao Ma
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Susan K Lipka
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Joan Rimar
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Peter Longley
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Teresita Vega
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Javier Perez-Irizarry
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Edieal Pinker
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| | - Rogerio Lilenbaum
- Yale Cancer Center and Smilow Cancer Hospital, Yale School of Management, and Yale New Haven Health, New Haven, CT; and Massachusetts General Hospital, Boston, MA
| |
Collapse
|
21
|
Hicks K, Downey L, Engelberg RA, Fausto JA, Starks H, Dunlap B, Sibley J, Lober W, Khandelwal N, Loggers ET, Curtis JR. Predictors of Death in the Hospital for Patients with Chronic Serious Illness. J Palliat Med 2017; 21:307-314. [PMID: 28926294 DOI: 10.1089/jpm.2017.0127] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Most people prefer to die at home, yet most do not. Understanding factors associated with terminal hospitalization may inform interventions to improve care. OBJECTIVE Among patients with chronic illness receiving care in a multihospital healthcare system, we identified the following: (1) predictors of death in any hospital; (2) predictors of death in a hospital outside the system; and (3) trends from 2010 to 2015. DESIGN Retrospective cohort using death certificates and electronic health records. Settings/Subjects: Decedents with one of nine chronic illnesses. RESULTS Among 20,486 decedents, those most likely to die in a hospital were younger (odds ratio [OR] 0.977, confidence interval [CI] 0.974-0.980), with more comorbidities (OR 1.188, CI 1.079-1.308), or more outpatient providers (OR 1.031, CI 1.015-1.047); those with cancer or dementia, or more outpatient visits were less likely to die in hospital. Among hospital deaths, patients more likely to die in an outside hospital had lower education (OR 0.952, CI 0.923-0.981), cancer (OR 1.388, CI 1.198-1.608), diabetes (OR 1.507, CI 1.262-1.799), fewer comorbidities (OR 0.745, CI 0.644-0.862), or fewer hospitalizations within the system during the prior year (OR 0.900, CI 0.864-0.938). Deaths in hospital did not change from 2010 to 2015, but the proportion of hospital deaths outside the system increased (p < 0.022). CONCLUSIONS Patients dying in the hospital who are more likely to die in an outside hospital, and therefore at greater risk for inaccessibility of advance care planning, were more likely to be less well-educated and have cancer or diabetes, fewer comorbidities, and fewer hospitalizations. These findings may help target interventions to improve end-of-life care.
Collapse
Affiliation(s)
- Katy Hicks
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,2 Department of Medicine, University of Washington , Seattle, Washington
| | - Lois Downey
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,3 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington , Seattle, Washington
| | - Ruth A Engelberg
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,2 Department of Medicine, University of Washington , Seattle, Washington.,3 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington , Seattle, Washington
| | - James A Fausto
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,4 Department of Family Medicine, University of Washington , Seattle, Washington
| | - Helene Starks
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,4 Department of Family Medicine, University of Washington , Seattle, Washington.,5 Department of Bioethics and Humanities, University of Washington , Seattle, Washington
| | - Ben Dunlap
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,3 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington , Seattle, Washington
| | - James Sibley
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,6 Department of Bioinformatics and Medical Education, University of Washington , Seattle, Washington
| | - William Lober
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,6 Department of Bioinformatics and Medical Education, University of Washington , Seattle, Washington
| | - Nita Khandelwal
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,7 Department of Anesthesiology and Pain Medicine, University of Washington , Seattle, Washington
| | - Elizabeth T Loggers
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,2 Department of Medicine, University of Washington , Seattle, Washington.,8 Seattle Cancer Care Alliance , Seattle, Washington.,9 Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle, Washington
| | - J Randall Curtis
- 1 Cambia Palliative Care Center of Excellence, University of Washington , Seattle, Washington.,2 Department of Medicine, University of Washington , Seattle, Washington.,3 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington , Seattle, Washington.,5 Department of Bioethics and Humanities, University of Washington , Seattle, Washington
| |
Collapse
|
22
|
Aldridge MD, Epstein AJ, Brody AA, Lee EJ, Morrison RS, Bradley EH. Association between Hospice Spending on Patient Care and Rates of Hospitalization and Medicare Expenditures of Hospice Enrollees. J Palliat Med 2017; 21:55-61. [PMID: 28817376 DOI: 10.1089/jpm.2017.0101] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND Care at the end of life is increasingly fragmented and is characterized by multiple hospitalizations, even among patients enrolled with hospice. OBJECTIVE To determine whether hospice spending on direct patient care (including the cost of home visits, drugs, equipment, and counseling) is associated with hospital utilization and Medicare expenditures of hospice enrollees. DESIGN Longitudinal, observational cohort study (2008-2010). SETTING/SUBJECTS Medicare beneficiaries (N = 101,261) enrolled in a national random sample of freestanding hospices (N = 355). MEASUREMENTS We used Medicare Hospice Cost reports to estimate hospice spending on direct patient care and Medicare claim data to estimate rates of hospitalization and Medicare expenditures. RESULTS Hospice mean direct patient care costs were $86 per patient day, the largest component being patient visits by hospice staff (e.g., nurse, physician, and counselor visits). After case-mix adjustment, hospices spending the most on direct patient care had patients with 5.2% fewer hospital admissions, 6.3% fewer emergency department visits, 1.6% fewer intensive care unit stays, and $1,700 less in nonhospice Medicare expenditures per patient compared with hospices spending the least on direct patient care (p < 0.01 for each comparison). Ninety percent of hospices with the lowest spending on direct patient care and highest rates of hospital use were for-profit hospices. CONCLUSIONS Patients cared for by hospices with lower direct patient care costs had higher hospitalization rates and were overrepresented by for-profit hospices. Greater investment by hospices in direct patient care may help Centers for Medicare and Medicaid Services avoid high-cost hospital care for patients at the end of life.
Collapse
Affiliation(s)
- Melissa D Aldridge
- 1 Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai , New York, New York.,2 Geriatrics Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center , Bronx, New York
| | - Andrew J Epstein
- 3 Leonard Davis Institute of Health Economics and Division of Internal Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania
| | - Abraham A Brody
- 2 Geriatrics Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center , Bronx, New York.,4 Hartford Institute for Geriatric Nursing, New York University College of Nursing , New York, New York
| | - Eric J Lee
- 1 Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai , New York, New York
| | - R Sean Morrison
- 1 Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai , New York, New York.,2 Geriatrics Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center , Bronx, New York
| | - Elizabeth H Bradley
- 5 Department of Health Policy and Management, Yale School of Public Health , New Haven, Connecticut.,6 Yale Global Health Leadership Institute , New Haven, Connecticut
| |
Collapse
|
23
|
Rajeshuni N, Johnston EE, Saynina O, Sanders LM, Chamberlain LJ. Disparities in location of death of adolescents and young adults with cancer: A longitudinal, population study in California. Cancer 2017; 123:4178-4184. [DOI: 10.1002/cncr.30860] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2017] [Revised: 05/04/2017] [Accepted: 05/29/2017] [Indexed: 11/08/2022]
Affiliation(s)
| | - Emily E. Johnston
- Division of Hematology/Oncology; Department of Pediatrics, Stanford University School of Medicine; Stanford California
| | - Olga Saynina
- Center for Health Policy; Freeman Spogli Institute, Stanford University School of Medicine; Stanford California
- Center for Primary Care and Outcomes Research; Department of Medicine, Stanford University; Stanford California
- Division of General Pediatrics; Department of Pediatrics, Stanford University School of Medicine; Stanford California
| | - Lee M. Sanders
- Center for Health Policy; Freeman Spogli Institute, Stanford University School of Medicine; Stanford California
- Center for Primary Care and Outcomes Research; Department of Medicine, Stanford University; Stanford California
- Division of General Pediatrics; Department of Pediatrics, Stanford University School of Medicine; Stanford California
| | - Lisa J. Chamberlain
- Center for Health Policy; Freeman Spogli Institute, Stanford University School of Medicine; Stanford California
- Center for Primary Care and Outcomes Research; Department of Medicine, Stanford University; Stanford California
- Division of General Pediatrics; Department of Pediatrics, Stanford University School of Medicine; Stanford California
| |
Collapse
|
24
|
Adelson K, Paris J, Horton JR, Hernandez-Tellez L, Ricks D, Morrison RS, Smith CB. Standardized Criteria for Palliative Care Consultation on a Solid Tumor Oncology Service Reduces Downstream Health Care Use. J Oncol Pract 2017; 13:e431-e440. [PMID: 28306372 DOI: 10.1200/jop.2016.016808] [Citation(s) in RCA: 103] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE Hospitalized patients with advanced cancer have a high symptom burden and need for support. Integration of palliative care (PC) improves symptom control and decreases unwanted health care use, yet many patients are never offered these services. In 2016, ASCO called for incorporation of PC into oncologic care for all patients with metastatic cancer. To improve the quality of cancer care, we developed standardized criteria, or triggers, for PC consultation on the inpatient solid tumor service. METHODS Patients were eligible for this prospective cohort study if they met at least one of the following eligibility criteria: had an advanced solid tumor; prior hospitalization within 30 days; hospitalization > 7 days; and active symptoms. During the intervention, patients who met the criteria received automatic PC consultation. RESULTS When we compared patients in the intervention group with control subjects, there were increases in PC consultations (19 of 48 [39%] to 52 of 65 [80%]; P ≤ .001) and hospice referrals (seven of 48 [14%] to 17 of 65 [26%]; P = .03), and there were declines in 30-day readmission rates (17 of 48 [35%] to 13 of 65 [18%]; P = .04) and receipt of chemotherapy after discharge (21 of 48 [44%] to 12 of 65 [18%]; P = .03). There was an overall increase in support measures following discharge ( P = .004). Length of stay was unaffected. CONCLUSION To our knowledge, this is the first study to demonstrate that among patients with advanced cancer admitted to an inpatient oncology service, the standardized use of triggers for PC consultation is associated with substantial impact on 30-day readmission rates, chemotherapy following discharge, hospice referrals, and use of support services following discharge. Expansion of this model to other hospitals and health systems should improve the value of cancer care.
Collapse
Affiliation(s)
- Kerin Adelson
- Yale University School of Medicine, New Haven, CT; New York University; Icahn School of Medicine at Mount Sinai, New York, NY; and Brigham and Women's Hospital, Boston, MA
| | - Julia Paris
- Yale University School of Medicine, New Haven, CT; New York University; Icahn School of Medicine at Mount Sinai, New York, NY; and Brigham and Women's Hospital, Boston, MA
| | - Jay R Horton
- Yale University School of Medicine, New Haven, CT; New York University; Icahn School of Medicine at Mount Sinai, New York, NY; and Brigham and Women's Hospital, Boston, MA
| | - Lorena Hernandez-Tellez
- Yale University School of Medicine, New Haven, CT; New York University; Icahn School of Medicine at Mount Sinai, New York, NY; and Brigham and Women's Hospital, Boston, MA
| | - Doran Ricks
- Yale University School of Medicine, New Haven, CT; New York University; Icahn School of Medicine at Mount Sinai, New York, NY; and Brigham and Women's Hospital, Boston, MA
| | - R Sean Morrison
- Yale University School of Medicine, New Haven, CT; New York University; Icahn School of Medicine at Mount Sinai, New York, NY; and Brigham and Women's Hospital, Boston, MA
| | - Cardinale B Smith
- Yale University School of Medicine, New Haven, CT; New York University; Icahn School of Medicine at Mount Sinai, New York, NY; and Brigham and Women's Hospital, Boston, MA
| |
Collapse
|
25
|
Liu SK, Ward M, Montgomery J, Mecchella JN, Masutani R, Bartels SJ, Batsis JA. Association of Hospital Admission Risk Profile Score with Mortality in Hospitalized Older Adults. Innov Aging 2017; 1:igx007. [PMID: 30480106 PMCID: PMC6218017 DOI: 10.1093/geroni/igx007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2017] [Accepted: 07/14/2017] [Indexed: 11/24/2022] Open
Abstract
OBJECTIVES To evaluate the association of the Hospital Admission Risk Profile (HARP) score with mortality after discharge in a population of hospitalized older adults. DESIGN Retrospective cohort study. PARTICIPANTS Hospitalized patients aged 70 years or older. MEASUREMENTS Patient age at the time of admission, modified Folstein Mini-Mental Status Exam score, and self-reported instrumental activities of daily living 2 weeks prior to admission were used to calculate a HARP score. The primary outcome assessed was overall mortality up to 365 days after hospital discharge. Cox proportional hazard analyses evaluated the association between HARP score and mortality adjusting for age, sex, and comorbidities associated with increased mortality. RESULTS Of the 474 patients, 165 (34.8%) had a low HARP score, 177 (37.4%) had an intermediate, and 132 (27.8%) had a high score. HARP score was not associated with differences in 30-day readmission rates. High HARP score patients had higher mortality when compared to patients with low HARP scores at all time frames (30 days: 12.9% vs 1.8%, p < .05; 90 days: 19.7% vs 4.8%, p < .05; 365 days: 34.8% vs 16.9%, p < .05). In fully adjusted Cox proportional models, patients with high HARP scores had a 3.5 times higher odds of mortality when compared to low HARP score patients. CONCLUSION The HARP score is a simple and easy to use instrument that identifies patients at increased risk for mortality after hospital discharge. Early identification of patients at increased risk for mortality has the potential to help guide treatment decisions following hospital discharge and provides additional information to providers and patients for shared decision making and may help in clarifying and achieving patient and family goals of care.
Collapse
Affiliation(s)
- Stephen K Liu
- Section of General Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
- Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
| | - Marshall Ward
- Section of General Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | - Justin Montgomery
- Section of General Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | - John N Mecchella
- Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
- Section of Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | | | - Stephen J Bartels
- Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
- Department of Psychiatry, Dartmouth-Hitchcock, Lebanon, New Hampshire
- Centers for Health and Aging, Dartmouth College, Lebanon, New Hampshire
| | - John A Batsis
- Section of General Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
- Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
- Centers for Health and Aging, Dartmouth College, Lebanon, New Hampshire
- The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, New Hampshire
| |
Collapse
|
26
|
Bainbridge D, Bryant D, Seow H. Capturing the Palliative Home Care Experience From Bereaved Caregivers Through Qualitative Survey Data: Toward Informing Quality Improvement. J Pain Symptom Manage 2017; 53:188-197. [PMID: 27720792 DOI: 10.1016/j.jpainsymman.2016.08.007] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/19/2016] [Revised: 07/26/2016] [Accepted: 08/04/2016] [Indexed: 11/18/2022]
Abstract
CONTEXT Measuring palliative care experience using patient-reported outcomes is becoming important for assessing and improving quality, although most validated outcome tools solely use scaled questions. OBJECTIVES We analyzed open-text survey responses from bereaved caregivers to identify strengths and weaknesses in the quality of end-of-life care services and to assess the usefulness of qualitative survey data for quality improvement. METHODS This was a retrospective observational study involving bereaved caregivers of decedents who had received palliative home care services in one of six health care regions in Ontario, Canada. Using the U.K.'s validated Views of Informal Carers-Evaluation of Services survey, respondents were asked what was good and what was bad about the services provided in the last three months of life as separate open-text questions. A qualitative constant comparison approach was used to derive themes from the responses. RESULTS Among 330 caregivers who completed the survey, 271 (82%) caregivers responded to the open-text questions: 93% of those commented on something that was good about care and 55% on something that was bad. The care experiences were generally positive, with the exception of specific individuals or settings that were perceived as adverse. The qualitative data were more informative about deficiencies in care compared with the quantitative data. CONCLUSION The qualitative survey data in this study provided key recommendations toward making care more responsive to the needs of dying patients and their families. Capturing the narrative responses of bereaved caregivers is feasible and informative for palliative care program development.
Collapse
Affiliation(s)
- Daryl Bainbridge
- Department of Oncology, McMaster University, Hamilton, Ontario, Canada; Juravinski Cancer Centre, Hamilton, Ontario, Canada.
| | | | - Hsien Seow
- Department of Oncology, McMaster University, Hamilton, Ontario, Canada; Juravinski Cancer Centre, Hamilton, Ontario, Canada; Escarpment Cancer Research Institute, Hamilton, Ontario, Canada
| |
Collapse
|
27
|
Shin JA, Parkes A, El-Jawahri A, Traeger L, Knight H, Gallagher ER, Temel JS. Retrospective evaluation of palliative care and hospice utilization in hospitalized patients with metastatic breast cancer. Palliat Med 2016; 30:854-61. [PMID: 26979670 PMCID: PMC5021562 DOI: 10.1177/0269216316637238] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND Hospitalizations in patients with metastatic cancer occur commonly at the end of life but have not been well-described in individuals with metastatic breast cancer. AIM To describe the reasons for admission and frequency of palliative care and hospice utilization in hospitalized patients with metastatic breast cancer. DESIGN This was a retrospective chart review of patients who had their first hospitalization with a diagnosis of metastatic breast cancer between 1 January 2009 and 31 December 2010. To standardize follow-up time, we collected data for 3 years post the index hospitalization. SETTING/PARTICIPANTS We identified 123 consecutive patients who were hospitalized for the first time with a diagnosis of metastatic breast cancer at a single, tertiary care center. RESULTS Uncontrolled symptoms accounted for half (50%, 62/123) of index admissions. The majority of patients died during the follow-up period (76%, 94/123), and the median time from index admission to death was 6 months (range: 0-34 months). Approximately half (53%, 50/94) died in the hospital or within 14 days of last hospital discharge, and less than one-third (29%, 27/94) were referred to hospice after their last hospitalization. The inpatient palliative care team evaluated 57% (54/94) of those who died at least once during an admission, but only 17% (16/94) of patients attended an outpatient palliative care appointment. CONCLUSIONS Hospitalized patients with metastatic breast cancer are commonly admitted for uncontrolled symptoms and have a poor prognosis. However, only a minority receive outpatient palliative care or are referred to hospice during their last hospitalization prior to death.
Collapse
Affiliation(s)
- Jennifer A Shin
- Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA
| | | | - Areej El-Jawahri
- Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA
| | - Lara Traeger
- Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | - Helen Knight
- Johns Hopkins School of Medicine, Baltimore, MD, USA
| | - Emily R Gallagher
- Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA
| | - Jennifer S Temel
- Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA
| |
Collapse
|
28
|
Adelson KB, Velji S, Patel K, Chaudhry B, Lyons C, Lilenbaum R. Preparing for Value-Based Payment: A Stepwise Approach for Cancer Centers. J Oncol Pract 2016; 12:e924-e932. [DOI: 10.1200/jop.2016.014605] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Most cancer centers are ill-equipped to pursue value-based payment (VBP) because of limited information on their population’s cost of care. Herein, we outline the stepwise approach used by Smilow Cancer Hospital at Yale-New Haven in our pursuit of better value care. First, we addressed institutional barriers. A move toward value required demonstration to Yale-New Haven Health System leadership that OCM would improve patient care, fund new infrastructure, and provide the opportunity to gain experience with VBP without a major threat to the financial stability of the health system. We evaluated patterns of care and found that of patients presenting to the emergency department (ED), 88% were admitted, 62% arrived during the workday, and 50% could have been stabilized with urgent care services. Within 30 days of death, 27% were admitted to the intensive care unit, 38% presented to the ED, and 52% were admitted. To quantify total cost of care, we accessed the 5% Medicare Limited Data Set to map out total cost of care for patients receiving chemotherapy at Smilow Cancer Hospital. Costs increased as patients moved through 6-month episodes, used the ED (patients with two or more visits were twice as expensive as those with one or fewer), or died during an episode (costs were twice as high as episodes in which the patient lived). To determine strategic interventions to improve value, we targeted investments in urgent care to reduce ED utilization, care management to prevent hospital admissions, and referral to palliative care for clarification of goals of care and avoidance of costly futile treatment. Developing internal metrics to evaluate success will require monitoring our interventions by having utilization measures for each site of care and individual provider.
Collapse
Affiliation(s)
- Kerin B. Adelson
- Yale Cancer Center/Smilow Cancer Hospital at Yale–New Haven, New Haven, CT; Brookings Institution; and Tuple Health, Washington, DC
| | - Salimah Velji
- Yale Cancer Center/Smilow Cancer Hospital at Yale–New Haven, New Haven, CT; Brookings Institution; and Tuple Health, Washington, DC
| | - Kavita Patel
- Yale Cancer Center/Smilow Cancer Hospital at Yale–New Haven, New Haven, CT; Brookings Institution; and Tuple Health, Washington, DC
| | - Basit Chaudhry
- Yale Cancer Center/Smilow Cancer Hospital at Yale–New Haven, New Haven, CT; Brookings Institution; and Tuple Health, Washington, DC
| | - Catherine Lyons
- Yale Cancer Center/Smilow Cancer Hospital at Yale–New Haven, New Haven, CT; Brookings Institution; and Tuple Health, Washington, DC
| | - Rogerio Lilenbaum
- Yale Cancer Center/Smilow Cancer Hospital at Yale–New Haven, New Haven, CT; Brookings Institution; and Tuple Health, Washington, DC
| |
Collapse
|
29
|
Brooks GA, Stuver SO, Zhang Y, Gottsch S, Fraile B, McNiff K, Dodek A, Jacobson JO. Characteristics Associated with In-Hospital Death among Commercially Insured Decedents with Cancer. J Palliat Med 2016; 20:42-47. [PMID: 27626711 DOI: 10.1089/jpm.2016.0231] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND A majority of patients with poor-prognosis cancer express a preference for in-home death; however, in-hospital deaths are common. OBJECTIVE We sought to identify characteristics associated with in-hospital death. DESIGN Case series. SETTING/SUBJECTS Commercially insured patients with cancer who died between July 2010 and December 2013 and who had at least two outpatient visits at a tertiary cancer center during the last six months of life. MEASUREMENTS Patient characteristics, healthcare utilization, and in-hospital death (primary outcome) were ascertained from institutional records and healthcare claims. Bivariate and multivariable analyses were used to evaluate the association of in-hospital death with patient characteristics and end-of-life outcome measures. RESULTS We identified 904 decedents, with a median age of 59 years at death. In-hospital death was observed in 254 patients (28%), including 110 (12%) who died in an intensive care unit. Hematologic malignancy was associated with a 2.57 times increased risk of in-hospital death (95% confidence interval [CI] 1.91-3.45, p < 0.001), and nonenrollment in hospice was associated with a 14.5 times increased risk of in-hospital death (95% CI 9.81-21.4, p < 0.001). Time from cancer diagnosis to death was also associated with in-hospital death (p = 0.003), with the greatest risk among patients dying within six months of cancer diagnosis. All significant associations persisted in multivariable analyses that were adjusted for baseline characteristics. CONCLUSIONS In-hospital deaths are common among commercially insured cancer patients. Patients with hematologic malignancy and patients who die without receiving hospice services have a substantially higher incidence of in-hospital death.
Collapse
Affiliation(s)
| | | | - Yichen Zhang
- 2 Dana-Farber Cancer Institute , Boston, Massachusetts
| | | | - Belen Fraile
- 2 Dana-Farber Cancer Institute , Boston, Massachusetts
| | | | - Anton Dodek
- 3 Blue Cross/Blue Shield of Massachusetts , Boston, Massachusetts
| | | |
Collapse
|
30
|
Aldridge MD, Epstein AJ, Brody AA, Lee EJ, Cherlin E, Bradley EH. The Impact of Reported Hospice Preferred Practices on Hospital Utilization at the End of Life. Med Care 2016; 54:657-63. [PMID: 27299952 PMCID: PMC5266506 DOI: 10.1097/mlr.0000000000000534] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
BACKGROUND The Affordable Care Act requires hospices to report quality measures across a range of processes and practices. Yet uncertainties exist regarding the impact of hospice preferred practices on patient outcomes. OBJECTIVE Assess the impact of 6 hospice preferred practices and hospice organizational characteristics on hospital utilization and death using the first national data on hospice preferred practices. DESIGN Longitudinal cohort study (2008-2011) of Medicare beneficiaries (N=149,814) newly enrolled in a national random sample of hospices (N=577) from the National Hospice Survey (84% response rate) and followed until death. OUTCOME MEASURES The proportion of patients at each hospice admitted to the hospital, emergency department (ED), and intensive care unit (ICU), and who died in the hospital after hospice enrollment. RESULTS Hospices that reported assessing patient preferences for site of death at admission had lower odds of being in the highest quartile for hospital death (AOR=0.36; 95% CI, 0.14-0.93) and ED visits (AOR=0.27; 95% CI, 0.10-0.76). Hospices that reported more frequently monitoring symptoms had lower odds of being in the highest quartile for ICU stays (AOR=0.48; 95% CI, 0.24-0.94). In adjusted analyses, a higher proportion of patients at for-profit compared with nonprofit hospices experienced a hospital admission (15.3% vs. 10.9%, P<0.001), ED visit (21.8% vs. 15.6%, P<0.001), and ICU stay (5.1% vs. 3.0%, P<0.001). CONCLUSIONS Hospitalization of patients following hospice enrollment varies substantially across hospices. Two of the 6 preferred practices examined were associated with hospitalization rates and for-profit hospices had persistently high hospitalization rates regardless of preferred practice implementation.
Collapse
Affiliation(s)
- Melissa D Aldridge
- *Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York †Geriatrics Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, NY ‡Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA §New York University College of Nursing, New York, NY ∥Department of Epidemiology and Public Health, Yale School of Public Health, New Haven, CT
| | | | | | | | | | | |
Collapse
|
31
|
Gu D, Liu G, Vlosky DA, Yi Z. Factors Associated With Place of Death Among the Chinese Oldest Old. J Appl Gerontol 2016. [DOI: 10.1177/0733464806296057] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Based on 6,444 deceased respondents ages 80 to 105 years from the first three waves of the Chinese Longitudinal Healthy Longevity Survey, the authors use multilevel modeling to examine how community development, individual sociodemographic characteristics, health conditions, and health resources affect place of death. Results show that 92% of Chinese oldest old die at home, with 7% dying in hospitals and 1% at institutions. Analyses indicate that residents from relatively developed communities in China tend to have a higher chance of hospital and/or institutional deaths; individuals with higher socioeconomic status (SES) and worsening health are more likely to experience hospital deaths; those who have pension and/or public and/or collective free medical services are more likely to die in hospitals and/or institutions. The authors also propose a theory about place of death consisting of three evolutionary stages, which might explain the disparity in patterns of place of death in different societies.
Collapse
|
32
|
LeBlanc TW, O'Donnell JD, Crowley-Matoka M, Rabow MW, Smith CB, White DB, Tiver GA, Arnold RM, Schenker Y. Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract 2016; 11:e230-8. [PMID: 25784580 DOI: 10.1200/jop.2014.001859] [Citation(s) in RCA: 127] [Impact Index Per Article: 15.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
PURPOSE Patients with hematologic malignancies are less likely to receive specialist palliative care services than patients with solid tumors. Reasons for this difference are poorly understood. METHODS This was a multisite, mixed-methods study to understand and contrast perceptions of palliative care among hematologic and solid tumor oncologists using surveys assessing referral practices and in-depth semistructured interviews exploring views of palliative care. We compared referral patterns using standard statistical methods. We analyzed qualitative interview data using constant comparative methods to explore reasons for observed differences. RESULTS Among 66 interviewees, 23 oncologists cared exclusively for patients with hematologic malignancies; 43 treated only patients with solid tumors. Seven (30%) of 23 hematologic oncologists reported never referring to palliative care; all solid tumor oncologists had previously referred. In qualitative analyses, most hematologic oncologists viewed palliative care as end-of-life care, whereas most solid tumor oncologists viewed palliative care as a subspecialty that could assist with complex patient cases. Solid tumor oncologists emphasized practical barriers to palliative care referral, such as appointment availability and reimbursement issues. Hematologic oncologists emphasized philosophic concerns about palliative care referrals, including different treatment goals, responsiveness to chemotherapy, and preference for controlling even palliative aspects of patient care. CONCLUSION Most hematologic oncologists view palliative care as end-of-life care, whereas solid tumor oncologists more often view palliative care as a subspecialty for comanaging patients with complex cases. Efforts to integrate palliative care into hematologic malignancy practices will require solutions that address unique barriers to palliative care referral experienced by hematologic malignancy specialists.
Collapse
Affiliation(s)
- Thomas W LeBlanc
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| | - Jonathan D O'Donnell
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| | - Megan Crowley-Matoka
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| | - Michael W Rabow
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| | - Cardinale B Smith
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| | - Douglas B White
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| | - Greer A Tiver
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| | - Robert M Arnold
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| | - Yael Schenker
- Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA
| |
Collapse
|
33
|
Harano K, Yonemori K, Hirakawa A, Shimizu C, Katsumata N, Gemma A, Fujiwara Y, Tamura K. The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study. Breast Cancer 2015; 23:797-806. [PMID: 26439379 DOI: 10.1007/s12282-015-0643-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2015] [Accepted: 09/24/2015] [Indexed: 11/28/2022]
Abstract
BACKGROUND The social or familial factors influencing the location chosen for end-of-life (EOL) care for terminally ill breast cancer patients are unknown. METHODS We retrospectively analyzed 195 patients with recurrent or progressive breast cancer who received anticancer treatment at the National Cancer Center Hospital between January 2008 and May 2012. Detailed data concerning the patients' demographic, familial, and clinical characteristics were collected, and multivariate and Cox logistic regression analyses were performed to evaluate the impact of these characteristics on the place of EOL care and on survival, respectively. RESULTS Sixty-eight patients (34.9 %) died in a hospital, 26 patients (13.3 %) at home, and 101 patients (51.8 %) in hospice. Most of the patients having caregivers received EOL care at palliative care facilities (hospice or home) [odds ratio (OR) 2.57; 95 % confidence interval (CI) 1-6.6; p = 0.05]. In contrast, patients with factors suggesting a clinically severe status (performance status ≥2, use of opioids, delirium, and ascites) more often received EOL care in a hospital. Among patients who received EOL care at hospice or home, patients with minor children received EOL care at home (OR 0.08; 95 % CI 0.02-0.38; p = 0.001). Patients with brain metastases chose hospice (OR 12.37; 95 % CI 2.25-68.13; p = 0.004). Furthermore, having a caregiver was associated with prolonged survival (hazard ratio 0.62; 95 % CI 0.39-0.97; p = 0.035). CONCLUSION Familial factors such as having children and caregivers significantly influenced the place of EOL care for terminally ill breast cancer patients.
Collapse
Affiliation(s)
- Kenichi Harano
- Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. .,Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital, 1-396, Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, 211-0063, Japan.
| | - Kan Yonemori
- Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - Akihiro Hirakawa
- Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan
| | - Chikako Shimizu
- Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - Noriyuki Katsumata
- Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital, 1-396, Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, 211-0063, Japan
| | - Akihiko Gemma
- Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
| | - Yasuhiro Fujiwara
- Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - Kenji Tamura
- Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
| |
Collapse
|
34
|
Kim SJ, Han KT, Kim TH, Park EC. Does hospital need more hospice beds? Hospital charges and length of stays by lung cancer inpatients at their end of life: A retrospective cohort design of 2002-2012. Palliat Med 2015; 29:808-16. [PMID: 25881621 DOI: 10.1177/0269216315582123] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
BACKGROUND Previous studies found that hospice and palliative care reduces healthcare costs for end-of-life cancer patients. AIM To investigate hospital inpatient charges and length-of-stay differences by availability of hospice care beds within hospitals using nationwide data from end-of-life inpatients with lung cancer. DESIGN A retrospective cohort study was performed using nationwide lung cancer health insurance claims from 2002 to 2012 in Korea. SETTING AND PARTICIPANTS Descriptive and multi-level (patient-level and hospital-level) mixed models were used to compare inpatient charges and lengths of stay. Using 673,122 inpatient health insurance claims, we obtained aggregated hospital inpatient charges and lengths of stay from a total of 114,828 inpatients and 866 hospital records. RESULTS Hospital inpatient charges and length of stay drastically increased as patients approached death; a significant portion of hospital inpatient charges and lengths of stay occurred during the end-of-life period. According to our multi-level analysis, hospitals with hospice care beds tend to have significantly lower end-of-life hospital inpatient charges; however, length of stay did not differ. Hospitals with more hospice care beds were associated with reduction in hospital inpatient charges within 3 months before death. CONCLUSION Higher end-of-life healthcare hospital charges were found for lung cancer inpatients who were admitted to hospitals without hospice care beds. This study suggests that health policy-makers and the National Health Insurance program need to consider expanding the use of hospice care beds within hospitals and hospice care facilities for end-of-life patients with lung cancer in South Korea, where very limited numbers of resources are currently available.
Collapse
Affiliation(s)
- Sun Jung Kim
- Department of Health Administration and Management, College of Medical Science, Soonchunhyang University, Asan, Korea
| | - Kyu-Tae Han
- Department of Public Health, Yonsei University College of Medicine, Seoul, Korea Institute of Health Services Research, Yonsei University College of Medicine, Seoul, Korea
| | - Tae Hyun Kim
- Institute of Health Services Research, Yonsei University College of Medicine, Seoul, Korea Department of Hospital Administration, Graduate School of Public Health, Yonsei University, Seoul, Korea
| | - Eun-Cheol Park
- Institute of Health Services Research, Yonsei University College of Medicine, Seoul, Korea Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
| |
Collapse
|
35
|
Casarett D, Harrold J, Harris PS, Bender L, Farrington S, Smither E, Ache K, Teno J. Does Continuous Hospice Care Help Patients Remain at Home? J Pain Symptom Manage 2015; 50:297-304. [PMID: 25936937 DOI: 10.1016/j.jpainsymman.2015.04.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Revised: 04/03/2015] [Accepted: 04/13/2015] [Indexed: 10/23/2022]
Abstract
CONTEXT In the U. S., hospices sometimes provide high-intensity "continuous care" in patients' homes. However, little is known about the way that continuous care is used or what impact continuous care has on patient outcomes. OBJECTIVES To describe patients who receive continuous care and determine whether continuous care reduces the likelihood that patients will die in an inpatient unit or hospital. METHODS Data from 147,137 patients admitted to 11 U.S. hospices between 2008 and 2012 were extracted from the electronic medical records. The hospices are part of a research-focused collaboration. The study used a propensity score-matched cohort design. RESULTS A total of 99,687 (67.8%) patients were in a private home or nursing home on the day before death, and of these, 10,140 (10.2%) received continuous care on the day before death. A propensity score-matched sample (n = 24,658) included 8524 patients who received continuous care and 16,134 patients who received routine care on the day before death. Using the two matched groups, patients who received continuous care on the day before death were significantly less likely to die in an inpatient hospice setting (350/8524 vs. 2030/16,134; 4.1% vs. 12.6%) (odds ratio [OR] 0.29; 95% CI 0.27-0.34; P < 0.001). When patients were cared for by a spouse, the use of continuous care was associated with a larger decrease in inpatient deaths (OR 0.12; 95% CI 0.09-0.16; P < 0.001) compared with those patients cared for by other family members (OR 0.37; 95% CI 0.32-0.42; P < 0.001). It is possible that unmeasured covariates were not included in the propensity score match. CONCLUSION Use of continuous care on the day before death is associated with a significant reduction in the use of inpatient care on the last day of life, particularly when patients are cared for by a spouse.
Collapse
Affiliation(s)
- David Casarett
- Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
| | - Joan Harrold
- Hospice and Community Care, Lancaster, Pennsylvania, USA
| | - Pamela S Harris
- Kansas City Hospice & Palliative Care, Kansas City, Missouri, USA
| | - Laura Bender
- Penn Home Care and Hospice Services, Philadelphia, Pennsylvania, USA
| | | | | | | | - Joan Teno
- Brown University, Providence, Rhode Island, USA
| |
Collapse
|
36
|
LeBaron VT, Cooke A, Resmini J, Garinther A, Chow V, Quiñones R, Noveroske S, Baccari A, Smith PT, Peteet J, Balboni TA, Balboni MJ. Clergy Views on a Good Versus a Poor Death: Ministry to the Terminally Ill. J Palliat Med 2015; 18:1000-7. [PMID: 26317801 DOI: 10.1089/jpm.2015.0176] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Clergy are often important sources of guidance for patients and family members making medical decisions at the end-of-life (EOL). Previous research revealed spiritual support by religious communities led to more aggressive care at the EOL, particularly among minority patients. Understanding this phenomenon is important to help address disparities in EOL care. OBJECTIVE The study objective was to explore and describe clergy perspectives regarding "good" versus "poor" death within the participant's spiritual tradition. METHODS This was a qualitative, descriptive study. Community clergy from various spiritual backgrounds, geographical locations within the United States, and races/ethnicities were recruited. Participants included 35 clergy who participated in one-on-one interviews (N = 14) and two focus groups (N = 21). Semistructured interviews explored clergy viewpoints on factors related to a "good death." Principles of grounded theory were used to identify a final set of themes and subthemes. RESULTS A good death was characterized by wholeness and certainty and emphasized being in relationship with God. Conversely, a "poor death" was characterized by separation, doubt, and isolation. Clergy identified four primary determinants of good versus poor death: dignity, preparedness, physical suffering, and community. Participants expressed appreciation for contextual factors that affect the death experience; some described a "middle death," or one that integrates both positive and negative elements. Location of death was not viewed as a significant contributing factor. CONCLUSIONS Understanding clergy perspectives regarding quality of death can provide important insights to help improve EOL care, particularly for patients highly engaged with faith communities. These findings can inform initiatives to foster productive relationships between clergy, clinicians, and congregants and reduce health disparities.
Collapse
Affiliation(s)
| | - Amanda Cooke
- 3 Beth Israel Deaconness Medical Center , Boston, Massachusetts
| | | | | | - Vinca Chow
- 6 Brigham & Women's Hospital , Boston, Massachusetts
| | - Rebecca Quiñones
- 2 Dana-Farber Cancer Institute, Harvard Cancer Center , Boston, Massachusetts
| | - Sarah Noveroske
- 2 Dana-Farber Cancer Institute, Harvard Cancer Center , Boston, Massachusetts
| | | | - Patrick T Smith
- 8 Gordon-Conwell Theological Seminary , Boston, Massachusetts
| | - John Peteet
- 2 Dana-Farber Cancer Institute, Harvard Cancer Center , Boston, Massachusetts
| | - Tracy A Balboni
- 2 Dana-Farber Cancer Institute, Harvard Cancer Center , Boston, Massachusetts
| | - Michael J Balboni
- 2 Dana-Farber Cancer Institute, Harvard Cancer Center , Boston, Massachusetts
| |
Collapse
|
37
|
Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma. Am J Clin Oncol 2015; 38:235-41. [PMID: 23648436 DOI: 10.1097/coc.0b013e31829378f9] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVES To examine the patterns of utilization of radiation therapy, chemotherapy, surgery, and hospice at the end-of-life care for patients diagnosed with metastatic melanoma. METHODS We identified 816 Medicare beneficiaries toward who were 65 years of age or older, with pathologically confirmed metastatic malignant melanoma between January 1, 2000, and December 31, 2007. We evaluated trends and associations between sociodemographic and health service characteristics and the use of hospice care, chemotherapy, surgery, and radiation therapy. RESULTS We found increasing use of surgery for patients with metastatic melanoma from 13% in 2000 to 30% in 2007 (P=0.03 for trend), and no significant fluctuation in the use of chemotherapy (P=0.43) or radiation therapy (P=0.46). Older patients were less likely to receive radiation therapy or chemotherapy. The use of hospice care increased from 61% in 2000 to 79% in 2007 (P=0.07 for trend). Enrollment in short-term (1 to 3 d) hospice care use increased, whereas long-term hospice care (≥4 d) remained stable. Patients living in the SEER (Surveillance, Epidemiology and End Results) northeast and south regions were less likely to undergo surgery. Patients enrolled in long-term hospice care used significantly less chemotherapy, surgery, and radiation therapy. CONCLUSIONS Surgery and hospice care use increased over the years of this study, whereas the use of chemotherapy and radiation therapy remained consistent for patients diagnosed with metastatic melanoma.
Collapse
|
38
|
Nakayama H, Sunakawa Y, Shimada K. To Better Understand Emotions of Bereaved Caregivers Who Took Care of Patients at Home. J Clin Oncol 2015; 33:2227-2228. [DOI: 10.1200/jco.2015.61.8926] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/29/2023] Open
Affiliation(s)
| | - Yu Sunakawa
- Showa University Northern Yokohama Hospital, Kanagawa, Japan
| | - Ken Shimada
- Showa University Koto Toyosu Hospital, Tokyo, Japan
| |
Collapse
|
39
|
Tanriverdi O, Yavuzsen T, Akman T, Senler FC, Taskoylu BY, Turhal S, Komurcu S, Cehreli R, Yaren A, Ozyilkan O. The Perspective of Non-oncologist Physicians on Patients with Metastatic Cancer and Palliative Care (ALONE Study): A Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). JOURNAL OF CANCER EDUCATION : THE OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER EDUCATION 2015; 30:253-259. [PMID: 25631655 DOI: 10.1007/s13187-015-0794-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The aim of our study was to determine the perspective of non-oncologist physicians regarding their attitudes and beliefs associated with palliative care for patients with metastatic cancer. The study was planned as a cross-sectional survey, and non-oncologist physicians were reached via e-mail and social networking sites. The first part of the questionnaire involved demographic properties, the second part inquired as to the perspectives of participants regarding metastatic disease, and the third part was used to determine beliefs and attitudes about palliative care. All of the questions were five-point Likert-type questions. A total of 1734 physicians completed the questionnaire. The majority of participants were general surgeons or internal medicine specialists (21 and 18%, respectively), were male (61%), were younger than 50 years of age (54%), worked in the town center (67%), had more than 11 years of professional experience (57%), and worked in a hospital without an active oncology service (86%). A total of 71% of participants identified all patients with metastatic cancer as being terminal stage, 62% were unaware of palliative care techniques, 64% did not know about common supportive care options, 59% were against hospice, and 63% had no opinion on resuscitation. We determined that non-oncologist physicians believed that all patients with metastatic cancer are at the terminal stage and that palliative/supportive care is the oncologist's task. These data suggest that non-oncologist physicians would benefit from additional graduate and postgraduate courses on these topics.
Collapse
Affiliation(s)
- Ozgur Tanriverdi
- Department of Medical Oncology, Faculty of Medicine, Mugla Sıtkı Kocman University, Mugla Universtesi Egitim ve Arastirma Hastanesi, Onkoloji Poliklinigi, 48000, Mugla, Turkey,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Cheng HWB. Optimizing End-of-Life Care for Patients With Hematological Malignancy: Rethinking the Role of Palliative Care Collaboration. J Pain Symptom Manage 2015; 49:e5-6. [PMID: 25656326 DOI: 10.1016/j.jpainsymman.2015.01.008] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/15/2014] [Revised: 12/26/2014] [Accepted: 01/01/2015] [Indexed: 11/23/2022]
Affiliation(s)
- Hon-Wai Benjamin Cheng
- Palliative Medical Unit, Grantham Hospital, University of Hong Kong, Hong Kong SAR, China; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
| |
Collapse
|
41
|
Landrum LM, Blank S, Chen LM, Duska L, Bae-Jump V, Lee PS, Levine L, McCourt C, Moore KN, Urban RR. Comprehensive care in gynecologic oncology: The importance of palliative care. Gynecol Oncol 2015; 137:193-202. [DOI: 10.1016/j.ygyno.2015.02.026] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2014] [Accepted: 02/26/2015] [Indexed: 11/30/2022]
|
42
|
Wallace SK, Waller DK, Tilley BC, Piller LB, Price KJ, Rathi N, Haque S, Nates JL. Place of Death among Hospitalized Patients with Cancer at the End of Life. J Palliat Med 2015; 18:667-76. [PMID: 25927588 DOI: 10.1089/jpm.2014.0389] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND The majority of hospital deaths in the United States occur after ICU admission. The characteristics associated with the place of death within the hospital are not known for patients with cancer. OBJECTIVE The study objective was to identify patient characteristics associated with place of death among hospitalized patients with cancer who were at the end of life. METHODS A retrospective cohort study design was implemented. Subjects were consecutive patients hospitalized between 2003 and 2007 at a large comprehensive cancer center in the United States. Multinomial logistic regression analysis was used to identify patient characteristics associated with place of death (ICU, hospital following ICU, hospital without ICU) among hospital decedents. RESULTS Among 105,157 hospital discharges, 3860 (3.7%) died in the hospital: 42% in the ICU, 14% in the hospital following an ICU stay, and 44% in the hospital without ICU services. Individuals with the following characteristics had an increased risk of dying in the ICU: nonlocal residence, newly diagnosed hematologic or nonmetastatic solid tumor malignancies, elective admission, surgical or pediatric services. A palliative care consultation on admission was associated with dying in the hospital without ICU services. CONCLUSIONS Understanding existing patterns of care at the end of life will help guide decisions about resource allocation and palliative care programs. Patients who seek care at dedicated cancer centers may elect more aggressive care; thus the generalizability of this study is limited. Although dying in a hospital may be unavoidable for patients who have uncontrolled symptoms that cannot be managed at home, palliative care consultations with patients and their families in advance regarding end-of-life preferences may prevent unwanted admission to the ICU.
Collapse
Affiliation(s)
- Susannah K Wallace
- 1 Clinical Analytics and Informatics Department, The University of Texas MD Anderson Cancer Center , Houston, Texas
| | - Dorothy K Waller
- 2 Division of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Science Center School of Public Health , Houston, Texas
| | - Barbara C Tilley
- 3 Division of Biostatistics, The University of Texas Health Science Center School of Public Health , Houston, Texas
| | - Linda B Piller
- 2 Division of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Science Center School of Public Health , Houston, Texas
- 3 Division of Biostatistics, The University of Texas Health Science Center School of Public Health , Houston, Texas
| | - Kristen J Price
- 4 Critical Care Department, The University of Texas MD Anderson Cancer Center , Houston, Texas
| | - Nisha Rathi
- 4 Critical Care Department, The University of Texas MD Anderson Cancer Center , Houston, Texas
| | - Sajid Haque
- 4 Critical Care Department, The University of Texas MD Anderson Cancer Center , Houston, Texas
| | - Joseph L Nates
- 4 Critical Care Department, The University of Texas MD Anderson Cancer Center , Houston, Texas
| |
Collapse
|
43
|
Pitfalls in Communication That Lead to Nonbeneficial Emergency Surgery in Elderly Patients With Serious Illness. Ann Surg 2014; 260:949-57. [DOI: 10.1097/sla.0000000000000721] [Citation(s) in RCA: 104] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Yildirim B, Tanriverdi O. Evaluation of cancer patients admitted to the emergency department within one month before death in Turkey: what are the problems needing attention? Asian Pac J Cancer Prev 2014; 15:349-53. [PMID: 24528055 DOI: 10.7314/apjcp.2014.15.1.349] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Although previously studies have reported that most patients with malignancy prefer to die at home, this is not the real situation in clinical practice. AIM In this study, we aimed to determine the characteristics of Turkish cancer patients admitted to the emergency department (ED) within one month before death. MATERIALS AND METHOD This descriptive retrospective study focused on questions about how often and why patients with cancer visited the ED before death. A total of 107 individuals with cancer were divided into 2 groups: Group 1, patients with at least one visit in the final 4 weeks; and Group 2, patients with no visit to ED. Demographic and clinical features were compared between the two groups. STATISTICAL ANALYSES Descriptive statistical methods, statistical analysis for correlation, Student's t-test, chi-square tests and logistic regression were used. RESULTS At least one visit to ED within one month before death was reported for 64 (60%) of the 107 cases. Of these 64 (Group 1), 38% (n=24) were discharged and 9% (n=6) died in the ED. The most common site of the primary tumor was the lung (n=24, 38%) and the most common symptom was dyspnea (92%). With the other 43 (40%) cancer patients not presenting to the ED within one month before death, they were more likely to be female with another type of cancer. CONCLUSIONS Guidelines are needed for better management of cancer patients benefiting from visits to ED within the last month of life .
Collapse
Affiliation(s)
- Birdal Yildirim
- Department of Emergency Medicine, Education and Research Hospital, Mugla Sitki Kocman University, Mugla, Turkey E-mail :
| | | |
Collapse
|
45
|
Nordly M, Benthien KS, Von Der Maase H, Johansen C, Kruse M, Timm H, Vadstrup ES, Kurita GP, von Heymann-Horan AB, Sjøgren P. The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home. BMC Palliat Care 2014; 13:44. [PMID: 25242890 PMCID: PMC4169691 DOI: 10.1186/1472-684x-13-44] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2013] [Accepted: 09/05/2014] [Indexed: 01/22/2023] Open
Abstract
Background The focus of Specialized Palliative Care (SPC) is to improve care for patients with incurable diseases and their families, which includes the opportunity to make their own choice of place of care and ultimately place of death. The Danish Palliative Care Trial (DOMUS) aims to investigate whether an accelerated transition process from oncological treatment to continuing SPC at home for patients with incurable cancer results in more patients reaching their preferred place of care and death. The SPC in this trial is enriched with a manualized psychological intervention. Methods/Design DOMUS is a controlled randomized clinical trial with a balanced parallel-group randomization (1:1). The planned sample size is 340 in- and outpatients treated at the Department of Oncology at Copenhagen University Hospital. Patients are randomly assigned either to: a) standard care plus SPC enriched with a standardized psychological intervention for patients and caregivers at home or b) standard care alone. Inclusion criteria are incurable cancer with no or limited antineoplastic treatment options. Discussion Programs that facilitate transition from hospital treatment to SPC at home for patients with incurable cancer can be a powerful tool to improve patients’ quality of life and support family/caregivers during the disease trajectory. The present study offers a model for achieving optimal delivery of palliative care in the patient’s preferred place of care and attempt to clarify challenges. Trial registration Clinicaltrials.gov Identifier: NCT01885637
Collapse
Affiliation(s)
- Mie Nordly
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen DK-2100, Denmark ; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
| | - Kirstine Skov Benthien
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen DK-2100, Denmark ; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
| | - Hans Von Der Maase
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen DK-2100, Denmark
| | - Christoffer Johansen
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen DK-2100, Denmark ; Danish Cancer Society Research Center, Copenhagen, Denmark
| | - Marie Kruse
- The Danish Institute for Local and Regional Research, Copenhagen, Denmark
| | - Helle Timm
- Danish Knowledge Centre for Palliative Care, Copenhagen, University of Southern Denmark, Copenhagen, Denmark
| | - Eva Soelberg Vadstrup
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen DK-2100, Denmark
| | - Geana Paula Kurita
- Section of Palliative Medicine, Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark ; Multidisciplinary Pain Centre, Department of Neuroanaesthesiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
| | | | - Per Sjøgren
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark ; Section of Palliative Medicine, Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
| |
Collapse
|
46
|
Varani S, Dall'Olio FG, Messana R, Tanneberger S, Pannuti R, Pannuti F, Biasco G. Clinical and demographic factors associated to the place of death in advanced cancer patients assisted at home in Italy. PROGRESS IN PALLIATIVE CARE 2014. [DOI: 10.1179/1743291x14y.0000000094] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
47
|
Lira FS, Neto JCR, Seelaender M. Exercise training as treatment in cancer cachexia. Appl Physiol Nutr Metab 2014; 39:679-86. [DOI: 10.1139/apnm-2013-0554] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Cachexia is a wasting syndrome that may accompany a plethora of diseases, including cancer, chronic obstructive pulmonary disease, aids, and rheumatoid arthritis. It is associated with central and systemic increases of pro-inflammatory factors, and with decreased quality of life, response to pharmacological treatment, and survival. At the moment, there is no single therapy able to reverse cachexia many symptoms, which include disruption of intermediary metabolism, endocrine dysfunction, compromised hypothalamic appetite control, and impaired immune function, among other. Growing evidence, nevertheless, shows that chronic exercise, employed as a tool to counteract systemic inflammation, may represent a low-cost, safe alternative for the prevention/attenuation of cancer cachexia. Despite the well-documented capacity of chronic exercise to counteract sustained disease-related inflammation, few studies address the effect of exercise training in cancer cachexia. The aim of the present review was hence to discuss the results of cachexia treatment with endurance training. As opposed to resistance exercise, endurance exercise may be performed devoid of equipment, is well tolerated by patients, and an anti-inflammatory effect may be observed even at low-intensity. The decrease in inflammatory status induced by endurance protocols is paralleled by recovery of various metabolic pathways. The mechanisms underlying the response to the treatment are considered.
Collapse
Affiliation(s)
- Fábio Santos Lira
- Immunometabolism Research Group, Department of Physical Education, Universidade Estadual Paulista (UNESP), Presidente Prudente, SP, Brazil
| | - José Cesar Rosa Neto
- Immunometabolism Research Group, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil
| | - Marília Seelaender
- Cancer Metabolism Research Group, Institute of Biomedical Sciences, University of São Paulo (USP), Av. Lineu Prestes, 1524, CEP 05508-900, Butantã, São Paulo, SP, Brazil
| |
Collapse
|
48
|
Jarlbaek L, Christensen L, Bruera E, Gilså Hansen D. The epidemiology of long- and short-term cancer survivors. A population-based cohort study exploring denominators for rehabilitation and palliative care programs. Acta Oncol 2014; 53:493-501. [PMID: 24050517 DOI: 10.3109/0284186x.2013.831471] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
INTRODUCTION In this study, we present data from a population-based cohort of incident cancer patients separated in long- and short-term survivors. Our aim was to procure denominators for use in the planning of rehabilitation and palliative care programs. MATERIAL AND METHODS A registry-linkage cohort study. All cancer patients, diagnosed from 1993 to 2003 from a 470 000 large population, were followed individually from diagnosis to death or until 31 December 2008. Long-term survivors lived five years or more after the time of the cancer diagnosis (TOCD). Short-term survivors died less than five years after TOCD. RESULTS The cohort comprised 24 162 incident cancer patients with 41% long-term survivors (N = 9813). Seventy percent of the cohort was 60 + years at TOCD. The 14 349 short-term survivors' median survival was 0.6 year, and 78% died less than two years after TOCD. A 12 years' difference in age at TOCD was seen between long- and short-term survivors, with median ages of 60 versus 72 years, respectively. Females comprised 64% of long-term, and 46% of short-term survivors. The proportion of breast and lung cancers differed between the groups: Long-term survivors: 31% breast cancer, 2.4% lung cancer. Short-term survivors: 21% lung cancer, 7.2% breast cancer. Chemotherapy was provided to 15% of all patients, and to 10% of the 60 + year olds. DISCUSSION The epidemiology of long- and short-term survivors shows significant differences with regard to age at TOCD, cancer types and sex. Two-year crude cancer survival seems as a clinically relevant cut point for characterizing potential "denominators" for rehabilitation or palliative care programs. From this cohort of incident cancer patients, and using two-year survival as a cut point, it could be estimated that 54% would candidate to a "care trajectory" focusing on rehabilitation and 46% a "care trajectory" focusing on palliative care at TOCD.
Collapse
Affiliation(s)
- Lene Jarlbaek
- Danish Knowledge Center for Palliative Care (PAVI), University of Southern Denmark,
Odense, Denmark
- National Research Centre for Cancer Rehabilitation, Research Unit of General Practice, Institute of Public Health, University of Southern Denmark,
Odense, Denmark
- Department of Oncology, University Hospital of Southern Denmark,
Odense, Denmark
| | - Linda Christensen
- Department of Oncology, University Hospital of Southern Denmark,
Odense, Denmark
| | - Eduardo Bruera
- Department of Palliative Care and Rehabilitation Medicine, M. D. Anderson Cancer Center,
Houston, Texas
| | - Dorte Gilså Hansen
- National Research Centre for Cancer Rehabilitation, Research Unit of General Practice, Institute of Public Health, University of Southern Denmark,
Odense, Denmark
| |
Collapse
|
49
|
Cheng BHW, Sham MMK, Chan KY, Li CW, Au HY. Intensive palliative care for patients with hematological cancer dying in hospice: analysis of the level of medical care in the final week of life. Am J Hosp Palliat Care 2013; 32:221-5. [PMID: 24259405 DOI: 10.1177/1049909113512412] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Dying of hematological oncology patients often take place in respective hematology ward or intensive care unit rather than hospice. With the increased attention to quality palliative care for hematology patients, concerns regarding their level of medical care at end-of-life need to be addressed. We conducted a retrospective review of consecutive hematological oncology patients who succumbed in a palliative unit between July 2012 and August 2013. The primary outcome measure was their level of medical care received, including administration of antibiotics, total parenteral nutrition, blood sampling, GCSF injection and blood products transfusion, during their last seven days of life. During the last seven days of life, 85.7 % of patients had blood sampling and 23.8% of patients received G-CSF injection. Total parenteral nutrition was administered in 14.3% of patients. One-third of patients received transfusion of packed cells and nearly half of them received transfusion of platelet concentrates. Almost 90% of patients received antibiotics during their last week of life. Collaboration between hematology and palliative care has resulted in successful transition of hematologic cancer patients into hospice unit in their terminal phase of illness. However, their level of medical care, even approaching last seven days of life, remained intensive. Proper allocation of medical resources and future research regarding optimal end-of-life care for hematology patients are warranted.
Collapse
Affiliation(s)
- Benjamin Hon Wai Cheng
- Palliative Medical Unit, Grantham Hospital, 125 Wong Chuk Hang Road, Aberdeen, Hong Kong SAR, China Department of Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong SAR, China
| | - Michael Mau Kwong Sham
- Palliative Medical Unit, Grantham Hospital, 125 Wong Chuk Hang Road, Aberdeen, Hong Kong SAR, China
| | - Kwok Ying Chan
- Palliative Medical Unit, Grantham Hospital, 125 Wong Chuk Hang Road, Aberdeen, Hong Kong SAR, China
| | - Cho Wing Li
- Palliative Medical Unit, Grantham Hospital, 125 Wong Chuk Hang Road, Aberdeen, Hong Kong SAR, China
| | - Ho Yan Au
- Department of Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong SAR, China
| |
Collapse
|
50
|
Neergaard MA, Jensen AB, Olesen F, Vedsted P. Access to Outreach Specialist Palliative Care Teams among Cancer Patients in Denmark. J Palliat Med 2013; 16:951-7. [DOI: 10.1089/jpm.2012.0265] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Mette Asbjoern Neergaard
- The Palliative Team, Aarhus University Hospital, Aarhus, Denmark
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
| | | | - Frede Olesen
- The Research Unit for General Practice, Aarhus University, Aarhus, Denmark
| | - Peter Vedsted
- The Research Unit for General Practice, Aarhus University, Aarhus, Denmark
- The Research Centre for Cancer Diagnosis in Primary Care (CaP), The Research Unit for General Practice, Aarhus University, Aarhus, Denmark
| |
Collapse
|